JP2023518707A5 - - Google Patents
Info
- Publication number
- JP2023518707A5 JP2023518707A5 JP2022554548A JP2022554548A JP2023518707A5 JP 2023518707 A5 JP2023518707 A5 JP 2023518707A5 JP 2022554548 A JP2022554548 A JP 2022554548A JP 2022554548 A JP2022554548 A JP 2022554548A JP 2023518707 A5 JP2023518707 A5 JP 2023518707A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- patient
- wandering
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062994527P | 2020-03-25 | 2020-03-25 | |
| US62/994,527 | 2020-03-25 | ||
| US202063005913P | 2020-04-06 | 2020-04-06 | |
| US63/005,913 | 2020-04-06 | ||
| PCT/US2021/012587 WO2021194608A1 (en) | 2020-03-25 | 2021-01-08 | Methods of treating proteinopathy- associated wandering |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518707A JP2023518707A (ja) | 2023-05-08 |
| JP2023518707A5 true JP2023518707A5 (https=) | 2024-01-16 |
Family
ID=77855102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554548A Pending JP2023518707A (ja) | 2020-03-25 | 2021-01-08 | タンパク質症に関連する徘徊を治療する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11642352B2 (https=) |
| EP (1) | EP4125879A4 (https=) |
| JP (1) | JP2023518707A (https=) |
| CN (1) | CN115916187A (https=) |
| CA (1) | CA3170073A1 (https=) |
| MX (1) | MX2022011518A (https=) |
| WO (1) | WO2021194608A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022008513A (es) * | 2020-01-09 | 2022-08-08 | Woolsey Pharmaceuticals Inc | Metodos para tratar la deambulacion asociada con la demencia cortical. |
| WO2021216139A1 (en) | 2020-04-23 | 2021-10-28 | Woolsey Pharmaceuticals, Inc | Methods of using rho kinase inhibitors to treat alzheimer's disease |
| MX2023000600A (es) * | 2020-07-14 | 2023-02-13 | Woolsey Pharmaceuticals Inc | Metodos de tratamiento de proteinopatias. |
| CN118251226A (zh) * | 2021-11-12 | 2024-06-25 | 悟而喜制药公司 | 治疗肌萎缩性侧索硬化症的方法以及其给药方案 |
| US20240423998A1 (en) | 2021-11-29 | 2024-12-26 | Woolsey Pharmaceuticals, Inc. | Methods of treating agitation and other dementia-associated behavioral symptoms |
| EP4479035A4 (en) * | 2022-02-17 | 2026-02-25 | Woolsey Pharmaceuticals Inc | FASUDIL TASTE MASKING ORAL FORMULATIONS |
| CN118922193A (zh) * | 2022-02-17 | 2024-11-08 | 悟而喜制药公司 | 具有离子交换树脂的法舒地尔口服制剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3464012B2 (ja) | 1993-04-05 | 2003-11-05 | 旭化成株式会社 | 精神症候治療剤 |
| CN100444843C (zh) * | 1998-08-10 | 2008-12-24 | 旭化成制药株式会社 | 法舒地尔盐酸盐缓释口服制剂 |
| WO2005117896A1 (de) | 2004-06-03 | 2005-12-15 | Schering Aktiengesellschaft | Formulierungen, die fasudil, eine matrix und einem mantel enthalten |
| WO2008036459A2 (en) * | 2006-07-20 | 2008-03-27 | Borchardt Allen J | Inhibitors of rho kinase |
| WO2008019395A2 (en) | 2006-08-10 | 2008-02-14 | Translational Genomics Research Institute | Compounds for improving learning and memory |
| US20080044390A1 (en) | 2006-08-11 | 2008-02-21 | Xiaowei Jin | Methods and compositions for the treatment of neurodegenerative disorders |
| EP2285217A4 (en) | 2008-05-12 | 2011-06-08 | Amnestix Inc | CONNECTIONS TO IMPROVE LEARNING AND MEMORY |
| CN101612157A (zh) | 2008-06-26 | 2009-12-30 | 天津红日药业股份有限公司 | 法舒地尔诱导成年脑内源性神经干细胞再生的用途 |
| US20120010196A1 (en) * | 2010-04-02 | 2012-01-12 | Qin Quingyu | Methods of treating neurodegenerative disorders and diseases |
| US9980972B2 (en) | 2012-03-12 | 2018-05-29 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Rho kinase inhibitors for use in treating familial amyotrophic lateral sclerosis |
| WO2017195224A1 (en) | 2016-05-09 | 2017-11-16 | Istituto Superiore Di Sanita' | Rho gtpase activating bacterial toxins for use in the treatment of disorders of the central nervous system by mucosal administration |
| MX2022008513A (es) * | 2020-01-09 | 2022-08-08 | Woolsey Pharmaceuticals Inc | Metodos para tratar la deambulacion asociada con la demencia cortical. |
| WO2021216139A1 (en) * | 2020-04-23 | 2021-10-28 | Woolsey Pharmaceuticals, Inc | Methods of using rho kinase inhibitors to treat alzheimer's disease |
| MX2023000600A (es) * | 2020-07-14 | 2023-02-13 | Woolsey Pharmaceuticals Inc | Metodos de tratamiento de proteinopatias. |
-
2021
- 2021-01-08 US US17/144,802 patent/US11642352B2/en active Active
- 2021-01-08 WO PCT/US2021/012587 patent/WO2021194608A1/en not_active Ceased
- 2021-01-08 JP JP2022554548A patent/JP2023518707A/ja active Pending
- 2021-01-08 CN CN202180036165.2A patent/CN115916187A/zh active Pending
- 2021-01-08 CA CA3170073A patent/CA3170073A1/en active Pending
- 2021-01-08 MX MX2022011518A patent/MX2022011518A/es unknown
- 2021-01-08 EP EP21776897.7A patent/EP4125879A4/en not_active Withdrawn
-
2023
- 2023-03-24 US US18/189,478 patent/US20230226073A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518707A5 (https=) | ||
| DK2224917T3 (en) | Composition with nicotine and opipramol and its use | |
| KR100566701B1 (ko) | 고위험의 내당력 장애를 치료하기 위한 알파-글루코시다제억제제의 용도 | |
| JP5792061B2 (ja) | 神経及び精神障害の治療法 | |
| US11318144B2 (en) | Compositions and methods for treating Alzheimer's disease and Parkinson's disease | |
| KR102059027B1 (ko) | Hdac6 억제제를 유효성분으로 포함하는 가려움증 예방 또는 치료용 약제학적 조성물 | |
| JP2021080276A (ja) | デクスメデトミジン製剤を使用する睡眠障害の予防または治療 | |
| JP2002524498A (ja) | 機能性及び／又は器質性痛み症候群の治療のための製薬組成物の調製のためのアセチルコリンエステラーゼ阻害剤の使用 | |
| EP3813816B1 (en) | Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1s,3s)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid in the treatment of fragile x syndrome or fragile x-associated tremor/ataxia syndrome | |
| US6075028A (en) | Method of treating Tourette's syndrome and related CNS disorders | |
| JP2017505786A (ja) | 神経障害の処置のためのバクロフェン、アカンプロセート、及び中鎖トリグリセライドの併用 | |
| JP2019501207A (ja) | バレニクリンまたはこの薬学的に許容可能な塩を含有する、味の遮蔽された口腔投与用薬学製剤 | |
| WO2021262196A1 (en) | Compositions and methods for treating alzheimer's disease and parkinson's disease | |
| WO2019082128A1 (en) | DELAYED-RELEASE RELEASE TABLETS AND METHODS OF USE | |
| CA2985305C (en) | Combinations of opioids and n-acylethanolamines | |
| JP2024544500A5 (https=) | ||
| CN110585226B (zh) | 金线莲苷在制备改善认知功能障碍的药物中的用途 | |
| UA81052C2 (en) | Use of bicyclo [2.2.1] heptane derivatives for the preparation of neuroprotective pharmaceutical compositions for the reduction of the consequences of ischemic or traumatic brain and spinal damage | |
| WO2012129759A1 (en) | Oral dosage formulations containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders | |
| JPH07507280A (ja) | （−）−メトリフォネート含有薬剤 | |
| KR101503782B1 (ko) | 신경 세포사 억제제 | |
| CN121868499A (zh) | 一种预防或治疗神经系统变性疾病的方法和药物组合 | |
| JP2009501205A (ja) | 精神病治療用組成物 | |
| JP2004531480A (ja) | 神経変性疾患の処置のためのトリペプチド誘導体 | |
| HK40050398A (en) | Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1s,3s)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid in the treatment of fragile x syndrome or fragile x-associated tremor/ataxia syndrome |